Livzon Brand Ranking
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
LIVZON

LIVZON

Livzon Pharmaceutical Group Inc.
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
Brand Introduction

Lizhu Pharmaceutical Group Co., Ltd. was founded in January 1985 with a registered capital of 935 million yuan. It is a comprehensive pharmaceutical group company integrating pharmaceutical research and development, production and sales. It currently has more than 8,000 employees and is an A+H-share listed company. In 2021, the company's operating income was 12.06 billion yuan, net profit was 1.78 billion yuan, and R&D investment was 1.52 billion yuan.

Lizhu has made continuous breakthroughs in the fields of raw materials, chemical drugs, traditional Chinese medicines, biological drugs, in vitro diagnostic reagents, etc., and its products are distributed in digestive, cardiovascular, reproductive endocrine, mental/nervous fields. The company continues to focus on the main business of innovative drugs and high-barrier complex preparations, and has launched blockbuster products such as leuprolide and esprazole, achieving large-scale growth in the fields of digestive and reproductive.

Lizhu has formed a prescription drug marketing network that radiates across the country and is rapidly promoting the construction of a global sales platform. Through professional academic promotion and high-quality products with accurate efficacy, a good communication channel has been established with hospitals and patients.

Lizon's development is inseparable from the continuous joining of outstanding talents and the continuous high-growth R&D investment. The company has built a comprehensive network of scientists and continuously recruited talents around the world. The R&D team has hundreds of doctoral and high-end R&D personnel. In the future, Lizon will continue to focus on the field of life and health, continuously improve the quality of life of patients, continue to shoulder social responsibilities and mission responsibilities, actively participate in public welfare undertakings, and accelerate the company's pace towards globalization.

Recommend Related Products

版权所有 © 宁波全贸信息技术有限公司 浙ICP备12012821号-1 浙B2-20200628

浙公网安备 33020902000078号